Download This PaperDespite Steep Costs, Payments for New Cancer Drugs Make Economic Sense
Nature Medicine, Vol. 17, No. 244, 2011
2 Pages Posted: 26 Oct 2011
Date Written: July 2011
Abstract
Cancer drugs have become more expensive over the past few years, leading many people to question whether the treatments are really worth their high costs. But despite the sticker shock, cancer medicines have provided good value for money.
Suggested Citation: Suggested Citation
Lichtenberg, Frank R., Despite Steep Costs, Payments for New Cancer Drugs Make Economic Sense (July 2011). Nature Medicine, Vol. 17, No. 244, 2011 , Available at SSRN: https://ssrn.com/abstract=1949303
Frank R. Lichtenberg (Contact Author)
Columbia University - Columbia Business School, Finance ( email )
3022 Broadway
504 Uris Hall, Dept. of Finance & Economics
New York, NY 10027
United States
212-854-4408 (Phone)
212-316-9219 (Fax)
HOME PAGE: http://https://www8.gsb.columbia.edu/cbs-directory/detail/frl1
CESifo (Center for Economic Studies and Ifo Institute for Economic Research)
Poschinger Str. 5
Munich, DE-81679
Germany
Do you have negative results from your research you’d like to share?
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.